Germany vs Iraq: Cause of death, by non-communicable diseases, ages 60+, female
Germany
86.7%
in 2021
Iraq
86.6%
in 2021
Germany rank
19th
Iraq rank
20th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Germany
- Iraq
How they compare
Germany currently reports 86.7% against 86.6% in Iraq, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iraq ahead.
Germany ranks 19th and Iraq ranks 20th of 185 countries.
Across the 3 decades both report, Germany averaged higher in 1 and Iraq in 2.
Head to head by decade
| Decade | Germany | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.9% | 95.0% | 1.1% | Iraq |
| 2010s | 92.3% | 95.0% | 2.6% | Iraq |
| 2020s | 87.8% | 84.7% | 3.1% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Germany or Iraq?
- Germany, at 86.7% against 86.6% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Germany and Iraq?
- 0.1%, with Germany ahead.
- How many years of comparable data are there for Germany and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Germany and Iraq rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Germany ranks 19th and Iraq ranks 20th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.